Loading...
Docoh

024 Pharma (EEIG)

Filed: 10 May 17, 8:00pm

Exhibit 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

Section 1350 Certification

 

 

In connection with the Quarterly Report of 024 Pharma, Inc. (the “Company”), on Amendment No. 1 to Form 10-Q for the period ended March 31, 2017, as filed with the Securities Exchange Commission on the date hereof (the “Report”), the undersigned, in the capacities and on the dates indicated below, hereby certify, pursuant to and solely for the purpose of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

 

1.  The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and

 

2.  The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: May 10, 2017  By:/s/Miro Zecevic 
  Miro Zecevic 
  Chief Executive Officer and 
  Chief Financial Officer